On April 22, 2026, Secretary of Health and Human Services Robert F. Kennedy Jr. concluded four days of testimony before the House Energy and Commerce Committee. The hearings, marked by a mix of defiance and conciliation, centered on the administration’s Make America Healthy Again (MAHA) initiative and a sweeping proposal to reorganize the nation’s leading health agencies. Kennedy defended his first year in office, emphasizing a shift toward addressing chronic disease and environmental toxins while navigating friction with traditional public health institutions.
During the final session, Kennedy addressed the proposed 480 billion dollar budget for the Department of Health and Human Services (HHS) for the 2027 fiscal year. A significant portion of the debate focused on the Food and Drug Administration Modernization Act of 2026, which seeks to decouple the FDA’s funding from pharmaceutical industry user fees. Kennedy argued that the current funding model, where roughly 45 percent of the FDA’s budget comes from industry fees, creates a conflict of interest. He proposed a 3.2 billion dollar increase in direct federal appropriations to offset the loss of these fees, a move that faced sharp questioning from Representative Frank Pallone and other committee members.
The Secretary also faced scrutiny regarding the United States' relationship with the World Health Organization (WHO). Kennedy confirmed that the administration is reviewing its participation in the Pandemic Prevention, Preparedness and Response Accord, citing concerns over national sovereignty. On the domestic front, he detailed a new Transparency in Immunization protocol, which mandates the publication of raw clinical trial data for all vaccines approved by the CDC’s Advisory Committee on Immunization Practices (ACIP). While Kennedy maintained a combative stance on data access, he was notably contrite when addressing past statements on specific childhood vaccinations, clarifying that the administration does not seek a federal ban but rather informed consent and rigorous safety re-evaluation.
The testimony occurs against a backdrop of shifting global health alliances. Kennedy’s emphasis on nutritional sovereignty and the elimination of certain food additives has drawn both praise and criticism from international trade partners, particularly within the European Union, where similar bans are already in place. Within the U.S. government, the Secretary’s efforts to consolidate the functions of the CDC and the NIH into a more centralized National Health Security Agency represent the most significant structural change to federal health oversight since the creation of HHS in 1980.
Throughout the four days, Kennedy sought to balance the expectations of the White House with the demands of his MAHA base. He highlighted the Clean Food Initiative, which has already seen the removal of four synthetic dyes from federally funded school lunch programs. As the hearings concluded, Committee Chair Cathy McMorris Rodgers noted that while the Secretary’s vision for health reform is ambitious, the legislative path for the required funding and structural shifts remains uncertain in a divided Congress.